| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | - | - | - | - | - | - | - |
| 1 | - | - | - | - | - | - | - | - | - | - | - |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 5.5 |
| 1 | 13.0 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 155 |
| 1 | 477 |
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
| instance | NT | total connections | connections /#aMe9 (L) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe2 (R) | Glu | 7 | 3.5 | 30.4% | 30.4% |
| 1 | aMe9 (L) | ACh | 5 | 2.5 | 21.7% | 52.2% |
| 2 | aMe9 (R) | ACh | 2 | 1.0 | 8.7% | 60.9% |
| 3 | CL125 (R) | unclear | 2 | 1.0 | 8.7% | 69.6% |
| 4 | LoVC23 (L) | GABA | 2 | 1.0 | 8.7% | 78.3% |
| 5 | OA-AL2i3 (R) | OA | 2 | 1.0 | 8.7% | 87.0% |
| instance | NT | total connections | connections /#aMe9 (L) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | aMe15 (R) | unclear | 21 | 10.5 | 14.8% | 14.8% |
| 1 | aMe17b (R) | GABA | 18 | 9.0 | 12.7% | 27.5% |
| 2 | MeVP63 (R) | GABA | 15 | 7.5 | 10.6% | 38.0% |
| 3 | aMe23 (R) | unclear | 14 | 7.0 | 9.9% | 47.9% |
| 4 | SLP250 (R) | unclear | 7 | 3.5 | 4.9% | 52.8% |
| 5 | aMe4 (R) | ACh | 6 | 3.0 | 4.2% | 57.0% |
| 6 | aMe9 (L) | ACh | 5 | 2.5 | 3.5% | 60.6% |
| 7 | aMe9 (R) | ACh | 4 | 2.0 | 2.8% | 63.4% |
| 8 | CL063 (R) | unclear | 4 | 2.0 | 2.8% | 66.2% |
| 9 | MeVC21 (R) | Glu | 4 | 2.0 | 2.8% | 69.0% |
| 10 | MeVC22 (R) | Glu | 4 | 2.0 | 2.8% | 71.8% |
| 11 | MeVP29 (R) | ACh | 4 | 2.0 | 2.8% | 74.6% |
| 12 | aMe8 (R) | ACh | 3 | 1.5 | 2.1% | 76.8% |
| 13 | CL125 (R) | unclear | 3 | 1.5 | 2.1% | 78.9% |
| 14 | MeVPaMe1 (R) | ACh | 3 | 1.5 | 2.1% | 81.0% |
| 15 | aMe12 (R) | ACh | 2 | 1.0 | 1.4% | 82.4% |
| 16 | aMe2 (R) | Glu | 2 | 1.0 | 1.4% | 83.8% |
| 17 | DNp27 (R) | unclear | 2 | 1.0 | 1.4% | 85.2% |
| 18 | MeVP12 (R) | ACh | 2 | 1.0 | 1.4% | 86.6% |
| 19 | MeVPaMe1 (L) | ACh | 2 | 1.0 | 1.4% | 88.0% |